Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies

R. Albertini, R. Moratti, G. De Luca

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Although it has been known for long time that atherosclerosis is associated with lipid deposition, only recently it has been accepted that the plasmatic concentration of cholesterol, especially LDL cholesterol, is a risk factor for atherosclerosis. However, chemically modified LDL, but not native LDL, is able to induce the formation of foam cells, the hallmark of atherosclerosis. LDL oxidation is likely to be the most important form of LDL modification in humans. In biochemical terms, LDL oxidation is a free radical driven chain reaction where polyunsaturated fatty acids are converted to lipid peroxides, which easily decompose to many products, including biologically active aldehydes. The assay of LDL oxidation in biological fluids is problematic; direct assays detect a product of LDL oxidation whereas indirect assays give an indicator of LDL oxidation susceptibility. In general, epidemiological studies support the concept that the level of plasmatic lipophilic antioxidants, tocopherols and carotenoids, is low in populations at increased risk for atherosclerosis. However, clinical trials based on vitamin E as antioxidant showed inconclusive results, suggesting that supplementation with vitamin E is not generically recommended for atherosclerotic patients. These results, however, do not contradict that oxidation of lipoprotein is involved in atherosclerosis; rather, this negative outcome raises a number of considerations such as the need for a reliable marker of lipoprotein oxidation in plasma and a more complete information about the physiological triggers of lipoprotein oxidation.

Original languageEnglish
Pages (from-to)579-592
Number of pages14
JournalCurrent Molecular Medicine
Volume2
Issue number6
DOIs
Publication statusPublished - Sep 2002

Fingerprint

Biochemistry
LDL Lipoproteins
Atherosclerosis
Oxidation
Lipoproteins
Vitamin E
Assays
Antioxidants
Foam Cells
Tocopherols
Lipid Peroxides
Carotenoids
Unsaturated Fatty Acids
Aldehydes
LDL Cholesterol
Free Radicals
oxidized low density lipoprotein
Clinical Studies
Epidemiologic Studies
Cholesterol

Keywords

  • Antioxidants
  • Atherosclerosis
  • Lipid peroxidation
  • Low-density lipoprotein oxidation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. / Albertini, R.; Moratti, R.; De Luca, G.

In: Current Molecular Medicine, Vol. 2, No. 6, 09.2002, p. 579-592.

Research output: Contribution to journalArticle

@article{6d02e8c7a290442c94e6d59487bc0561,
title = "Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies",
abstract = "Although it has been known for long time that atherosclerosis is associated with lipid deposition, only recently it has been accepted that the plasmatic concentration of cholesterol, especially LDL cholesterol, is a risk factor for atherosclerosis. However, chemically modified LDL, but not native LDL, is able to induce the formation of foam cells, the hallmark of atherosclerosis. LDL oxidation is likely to be the most important form of LDL modification in humans. In biochemical terms, LDL oxidation is a free radical driven chain reaction where polyunsaturated fatty acids are converted to lipid peroxides, which easily decompose to many products, including biologically active aldehydes. The assay of LDL oxidation in biological fluids is problematic; direct assays detect a product of LDL oxidation whereas indirect assays give an indicator of LDL oxidation susceptibility. In general, epidemiological studies support the concept that the level of plasmatic lipophilic antioxidants, tocopherols and carotenoids, is low in populations at increased risk for atherosclerosis. However, clinical trials based on vitamin E as antioxidant showed inconclusive results, suggesting that supplementation with vitamin E is not generically recommended for atherosclerotic patients. These results, however, do not contradict that oxidation of lipoprotein is involved in atherosclerosis; rather, this negative outcome raises a number of considerations such as the need for a reliable marker of lipoprotein oxidation in plasma and a more complete information about the physiological triggers of lipoprotein oxidation.",
keywords = "Antioxidants, Atherosclerosis, Lipid peroxidation, Low-density lipoprotein oxidation",
author = "R. Albertini and R. Moratti and {De Luca}, G.",
year = "2002",
month = "9",
doi = "10.2174/1566524023362177",
language = "English",
volume = "2",
pages = "579--592",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies

AU - Albertini, R.

AU - Moratti, R.

AU - De Luca, G.

PY - 2002/9

Y1 - 2002/9

N2 - Although it has been known for long time that atherosclerosis is associated with lipid deposition, only recently it has been accepted that the plasmatic concentration of cholesterol, especially LDL cholesterol, is a risk factor for atherosclerosis. However, chemically modified LDL, but not native LDL, is able to induce the formation of foam cells, the hallmark of atherosclerosis. LDL oxidation is likely to be the most important form of LDL modification in humans. In biochemical terms, LDL oxidation is a free radical driven chain reaction where polyunsaturated fatty acids are converted to lipid peroxides, which easily decompose to many products, including biologically active aldehydes. The assay of LDL oxidation in biological fluids is problematic; direct assays detect a product of LDL oxidation whereas indirect assays give an indicator of LDL oxidation susceptibility. In general, epidemiological studies support the concept that the level of plasmatic lipophilic antioxidants, tocopherols and carotenoids, is low in populations at increased risk for atherosclerosis. However, clinical trials based on vitamin E as antioxidant showed inconclusive results, suggesting that supplementation with vitamin E is not generically recommended for atherosclerotic patients. These results, however, do not contradict that oxidation of lipoprotein is involved in atherosclerosis; rather, this negative outcome raises a number of considerations such as the need for a reliable marker of lipoprotein oxidation in plasma and a more complete information about the physiological triggers of lipoprotein oxidation.

AB - Although it has been known for long time that atherosclerosis is associated with lipid deposition, only recently it has been accepted that the plasmatic concentration of cholesterol, especially LDL cholesterol, is a risk factor for atherosclerosis. However, chemically modified LDL, but not native LDL, is able to induce the formation of foam cells, the hallmark of atherosclerosis. LDL oxidation is likely to be the most important form of LDL modification in humans. In biochemical terms, LDL oxidation is a free radical driven chain reaction where polyunsaturated fatty acids are converted to lipid peroxides, which easily decompose to many products, including biologically active aldehydes. The assay of LDL oxidation in biological fluids is problematic; direct assays detect a product of LDL oxidation whereas indirect assays give an indicator of LDL oxidation susceptibility. In general, epidemiological studies support the concept that the level of plasmatic lipophilic antioxidants, tocopherols and carotenoids, is low in populations at increased risk for atherosclerosis. However, clinical trials based on vitamin E as antioxidant showed inconclusive results, suggesting that supplementation with vitamin E is not generically recommended for atherosclerotic patients. These results, however, do not contradict that oxidation of lipoprotein is involved in atherosclerosis; rather, this negative outcome raises a number of considerations such as the need for a reliable marker of lipoprotein oxidation in plasma and a more complete information about the physiological triggers of lipoprotein oxidation.

KW - Antioxidants

KW - Atherosclerosis

KW - Lipid peroxidation

KW - Low-density lipoprotein oxidation

UR - http://www.scopus.com/inward/record.url?scp=0036729270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036729270&partnerID=8YFLogxK

U2 - 10.2174/1566524023362177

DO - 10.2174/1566524023362177

M3 - Article

C2 - 12243250

AN - SCOPUS:0036729270

VL - 2

SP - 579

EP - 592

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

IS - 6

ER -